Do not use Molnupiravur, Favipiravir, Azithromycin, Doxycycline, Ivermectin etc in COVID-19: ICMR revised guidelines
With a sudden spurt in COVID-19 cases across various parts of the country, the Indian Council of Medical Research (ICMR), the leading body for medical research has now issued revised guidelines for management of COVID-19
One of the major changes that are aimed to draw the attention of medical practitioners is the special DO NOT USE in COVID-19 Section that lists down various medicines including Lopinavir-ritonavir, HCQ, Ivermectin, Convalescent plasma, Molnupiravir, Favipiravir, Azithromycin, Doxycycline which are not be used for management of COVID-19
For more details, check out the link given below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd